Antivirals - Page 9 of 10 - GEN - Genetic Engineering and Biotechnology News

Antivirals

Pfizer and Clear Creek Bio to Collaborate on COVID-19 Antiviral Research Program

3d illustration - Virus Attack

Antivirals

An Inhibiting Enzyme Found That Boosts Innate Immune Response

Transparent Glass Bottles at Production Line

Antivirals

Tech Innovation Needed to Boost Capacity and Cut mAb Production Costs

Antivirals

Structural Insights into Viral Budding Unveil Potential Target for Deadly Diseases

Coronavirus 2019-nCoV spreading

Coronavirus

StockWatch: Humanigen Wilts after COVID-19 Antibody Fails NIH Trial

Antivirals

Chimerix Antiviral Candidate Brincidofovir Fails Phase III Trial

This image illustrates the start of an influenza infection. To date

Antivirals

Big Data Identifies the Flu’s Host Targets

Antivirals

J&J to Acquire HBV Drug Developer Novira Therapeutics

Antivirals

Ambidextrous Protein Grabs Hold of Latent HIV

Antivirals

Visterra Wins Up-to-$204.5M BARDA Contract; Reports Positive Phase IIa Results

Antivirals

Novavax Wins Up-to-$89M Gates Foundation Grant for RSV F Vaccine

Antivirals

Novel Cell-Based Screening Platform Identifies Potential New Antiviral Drugs

Antivirals

NOVEL STRATEGY FOR TREATMENT OF HIV AND OTHER VIRAL INFECTIONS

1...7 89Page 9 of 9